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Abstract
Justin Edward Reynolds: Investigating Actin-Myosin Mechanics to Model Heart Disease
Using Fluorescence Microscopy and Optical Trapping
(Under the direction of Dr. Nikki Reinemann)
Hypertrophic cardiomyopathy (HCM) is a hereditary disease in which the
myocardium becomes hypertrophied, making it more difficult for the heart to pump blood.
HCM is commonly caused by a mutation in the β-cardiac myosin II heavy chain. Myosin
is a motor protein that facilitates muscle contraction by converting chemical energy from
ATP hydrolysis into mechanical work and concomitantly moving along actin
filaments. Optical tweezers have been used previously to analyze single myosin
biophysical properties; however, myosin does not work as a single unit within the heart.
Multiple myosin interacts to displace actin filaments and do not have the same properties
as ensembles versus single molecules. We have engineered a more physiologically accurate
optical trapping approach using a hierarchical cytoskeleton structure consisting of multiple
myosin between two actin filaments that more closely models how myosin behaves within
the heart. The model was verified using fluorescent microscopy, and we analyzed the
biophysical properties of healthy myosin-actin complexes to lay the foundation for
studying diseased models in the future. For the healthy myosin model, we have measured
displacement profiles and force generation capacities using optical tweezers. This assay
allows us to not only analyze myosin in a more physiologically relevant environment but
also to study how multiple myosin interact within cardiac muscle cells.
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Introduction
As of 2017, the leading cause of death in the United States is due to heart disease1.

While most cardiac arrest deaths are in older adults, a rare group involves sudden cardiac
death in individuals under 35 years of age – especially in adolescent athletes 2. Many times,
these deaths occur with no warning, and are often due to unknown heart defects or
overlooked heart abnormalities2. A leading cause of sudden cardiac death in adolescent
athletes is hypertrophic cardiomyopathy (HCM).
HCM is a hereditary disease that is caused by gene mutations in the heart muscle 3–
5

. A common site for these mutations to occur is in the β-cardiac myosin heavy chains5.

Myosin is a molecular motor protein important for driving muscle contraction. These
myosin mutations affect the myocardium, or muscular tissue of the heart, and causes the
ventricular septum, the wall between the left and right ventricle in the heart, to grow
abnormally thick (Figure 1)4. The hypertrophy, or enlargement of the tissue due to the cell
size increasing, in the myocardium makes it harder for the heart to pump blood, which can
lead to complications such as atrial fibrillation, sudden cardiac death, obstructed blood
flow, dilated cardiomyopathy, mitral valve problems, or heart failure2,4. Many individuals
with HCM show minimal to no symptoms, but their condition could be exposed during
exercise3,4. Due to many individuals appearing asymptomatic, it commonly goes
undiagnosed in patients and is one of the leading underlying causes for sudden cardiac
death while exerting oneself3,4. While HCM outcomes have been studied in asymptomatic
patients, the molecular basis of the disease is not yet well understood 3–5. Studying HCM
from a molecular level will allow the scientific community to better understand how the
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molecular motor’s mechanical function differs between a normal cardiac muscle and the
mutated system seen in hypertrophic cardiomyopathy6.

Figure 1 Hypertrophic Cardiomyopathy (Illustrations of a normal heart (left) and a heart with hypertrophic
cardiomyopathy (HCM). Note that the heart walls (muscle) are much thicker (hypertrophied) in the HCM heart.) 4

Molecular motors are vital to living organisms. They are the proteins that transform
chemical energy into mechanical work through ATP hydrolysis7,8. In doing so, they
translocate cellular filaments, such as microtubules and actin, to perform large scale tasks,
such as controlling cell movement and division6,8. There are three types of molecular
motors, but for this study, cardiac myosin II is analyzed.
In order to better understand how the heart functions when healthy and in a diseased
state, we developed a novel assay that is more physiologically relevant than previous single
molecule studies of myosin to analyze the molecular basis of heart muscle contraction6.
Myosin’s force generating performance was measured using optical trapping and
fluorescence microscopy techniques9,10. Optical trapping allows for the measurement of
very precise mechanics of protein systems, with nanometer displacement and piconewton
2

force resolution6,11. Previous studies have been conducted using optical trapping, but those
studies have only analyzed myosin as a single unit acting on a single actin filament 6,12.
However, we know that this is not an accurate representation of the actin-myosin complex
in vivo. In cardiac muscle cells, multiple actin and myosin work together to cause heart
contractions. To mimic this function, we have engineered a more physiologically relevant
model of the actin-myosin complex. The new assay allows us to measure the molecularlevel mechanics of actin-myosin systems important for heart muscle contractions. The
capabilities measured will allow us to better understand the disease and give insight to the
molecular consequences of HCM.
The study of this hierarchical and more physiologically relevant model (see more
in Methods) will allow the scientific community to gain insight to the mechanical
differences between a normal actin-myosin complex compared to the mutated system. The
resolution of optical trapping will allow for the mechanics of molecular motor ensembles
to be studied more in depth and precisely than previously. Understanding the system from
a molecular level could reveal a pathway to exploit for therapeutic intervention and better
screen patients for this condition.

3

2

Background
2.1

Cardiac Muscle Function

Cardiac muscle tissue is a specialized form of muscle tissue that is responsible for
pumping blood to the entire body13. It is made up of many interlocking muscle fibers, and
each fiber is striated, containing a single nucleus. Cardiac muscle cells have evolved to
have high contractile strength and endurance14. It maintains its own rhythm and has the
ability to spread electrochemical signals that cause contraction in unison14–16. The striation
of the fiber can be used to see where the different components are, such as actin and
myosin. As seen in Figure 2, the dark bands are areas of thick protein filaments made up
of myosin (see more in Myosin), while the light bands are thin filaments made up of
primarily actin (see more in Actin). During muscle contractions, the myosin pulls the actin
filaments together causing the contractions13,14. The sinoatrial node (SA node) regulates
when the heart contracts (Figure 3). It is the heart’s natural pacemaker. The SA node causes
the action potential that leads to contraction. The signals from the SA node travel through
the internodal pathways to the atrioventricular node (AV node) down the bundle of His,
the fibers that deliver the electrical signal to the left and right ventricle, leading to activation
of the left and right ventricle. The potential is terminated in the Purkinje fibers14,16. The
cells are able to function in this way because they form a giant network of cardiac muscle
cells through their connection by their intercalated disks (Figure 4). The intercalated disks
form tight junctions between the cells holding them together while under strain and
allowing electrochemical signals to be passed quickly. This connection leads to the wavelike contraction pattern seen by the heart’s electrocardiogram13,14.

4

Figure 2 Histology of Muscle17

Figure 3 Electrical Signals of the Heart18

5

Figure 4 Cardiac Muscle and Electrical Activity15

2.2

Actin

Cardiac muscle contractions are conducted by two proteins – actin and myosin (see
more in Myosin). The myosin’s motor head pulls the actin filament causing it contract like
an accordion, and this leads to the muscle contractions in the heart (see more in ActinMyosin Complex). Actin is the major cytoskeletal protein for most cells and is the thinnest,
~7 nm in diameter, of the three principal types of filaments19. Actin filaments are abundant
in the cell and help provide mechanical support, determine cell shape, allow movement of
the cell surface, and act as a track for molecular motor movement12,19. It enables cells to
perform functions such as migration, engulfing particles, and dividing19. Globular,
monomeric actin proteins polymerize to form actin filaments, and these filaments are
organized into higher-order structures, forming bundles or three-dimensional networks,
6

within the cell19. Their assembly and disassembly, crosslinking into bundles, and
association with other cell structures are regulated by a variety of actin-binding proteins.
Actin filaments add and lose subunits only at their ends20,21. This is done through a process
called treadmilling. Treadmilling is a phenomenon observed in cytoskeletal filaments, and
it occurs when one end of a filament grows in length while the other end shrinks leading to
the seeming “moving” of the filament (Figure 5)8,19,20. The process of treadmilling, or actin
polymerization, requires ATP, and the subunits incorporate into the filament once ATP
hydrolyzes into ADP19,20. Treadmilling occurs because actin are structurally polar, but not
in the sense of electrostatics8. Polarity refers to the speed of polymerization and growth of
the filament. The “plus” or barbed end is the faster polymerizing end, and the “minus” or
pointed end is slower polymerizing. This structural polarity is important for directionality
of protein transport19,21.

Figure 5 Actin Treadmilling Process22
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2.3

Myosin

Myosin is another protein that plays a role in cardiac muscle contractions. Myosin,
a mechanoenzyme, is a molecular motor protein that converts chemical energy into
mechanical work7,12,23. They do this to transport and anchor organelles, vesicles, and other
intracellular components. Myosin are the only known actin-based motor protein and are a
large and diverse superfamily made up of many different classes8,23,24. In our study, we are
focused on the muscle myosin II family, which are responsible for muscle contraction in
skeletal as well as cardiac muscle through the ATPase cycle. The first myosin II was
discovered in 1864 by Willy Kuhne. Myosin II have long -helical tails and two heavy
chains with globular heads that have binding domains that are used to produce the “power
stroke” (see more in Actin-Myosin Complex) in the actin-myosin complex (Figure 6)23,24.
Myosin II aggregates to form thick filaments (Figure 6b) that interact with actin in the
cross-bridge cycle (Figure 7)8,17. The filaments are formed by the interaction of the
helical tail domains in an antiparallel orientation23,24.

8
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Figure 6 Myosin II Structure & Assembly24

2.4

Actin-Myosin Complex

The actin-myosin complex is responsible for muscle contraction through the
hydrolysis of ATP in the actin-myosin cross-bridge cycle8,12. The contractile elements are
in highly organized arrays the give the characterization patterns of cross-striations – such
as the light and dark bands in muscle fibers13,17. The sliding filament model is the currently
accepted model for muscle contractions, which was proposed in 1954 by Andrew Huxley,
Ralph Niedergerke, Hugh Huxley, and Jean Hanson25. During the muscle contraction, each
sarcomere, the contractile unit of the muscle cell composed of interacting myosin and actin
filaments, shortens similarly to an accordion25,26. The cross-bridge cycle begins with the
myosin head in its high energy conformation with ADP and Pi attached. The release of Pi

9

forms the cross-bridge with the myosin head cocking and binding to the actin filament.
Then, ADP is released and causing the power stroke and the contraction of the actin
filament. At this point, myosin is in its low energy conformation. ATP then binds to the
myosin head and releases it from the actin filament. ATP is hydrolyzed into ADP and Pi,
and the process restarts itself (Figure 7)8,25.

Figure 7 Actin-Myosin Cross-Bridge Cycle25

2.5

Optical Trapping

In our study, we used a biophysical technique called optical trapping to study the
biophysical properties of the actin-myosin complex6,27. The optical trap (optical tweezers)
was developed by Arthur Ashkin, and he was awarded the Nobel Prize in Physics in 2018
for his work28. Optical tweezers are able to use light to manipulate microscopic objects as
10

small as 10 nm using the radiation pressure from a focused laser beam 29. This instrument
is able to accurately measure distance and force down to a nanometer and piconewton
range, which allows for the mechanical properties of biological motors to be analyzed 29.
The trap functions because light has momentum10. When a highly focused laser beam with
a gaussian profile is passed through a glass or polystyrene bead, that bead experiences a
gradient force that pushed the bead to the center of the trap where the light intensity is the
highest (Figure 8)10,29. Since the photons focused around the bead are trapping it in the
center of the gaussian laser, the force generated by the molecular motor of interest can be
found by relating the distance the molecular motor pulls the bead from the center of the
trap to the force produced by using Hooke’s Law (see more in Theoretical Principles,
Figure 9).

Figure 8 Gradient Force (left image net force up towards the center of the trap laser; right image net force down towards
the center of the trap laser)30
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Figure 9 Hooke’s Law (Relates displacement to force of the attached molecular motor.)30

Optical trapping is a useful tool in our study because the force and position
resolution are on the same scale as molecular motor properties, such as force generation
capability, motor head step size, and velocity6,10,11. Here, we were mainly concerned with
the force generation capabilities of myosin, force mechanics of motor-filament assemblies,
as well as their displacement as single motors and as an ensemble. Optical tweezers are
able to analyze these molecular ensembles that are made up of multiple motors and actin
filaments, or an actin-myosin complex or “bundle”. Being able to analyze the force
generation capability and motor head step size of the “bundle” will help to gain insight to
understanding the molecular basis of hypertrophic cardiomyopathy6,12,27,31.

2.6

Fluorescence

Fluorescent microscopy is a technique used in this study to visualize the molecularlevel components of our assays. Fluorescence can be performed using a microscope with
an intense light source, such as an arc lamp or laser, and fluorophores or dyes in the
12

sample9. This tool is especially useful for biology because it provides high contrast of the
sample, has a high specificity, is a quantitative measure, and allows for live cell imaging32.
Fluorophores or a dye are added to stain the sample and create a better contrast between
structures9. Once the fluorophores or dyes are added and the sample is stained, light,
usually in the visible or ultraviolet (UV) range, is used to excite the fluorophores, causing
the emission of a lower energy light from the sample. This process causes changes in
electron energy states, as seen in a Jablonski diagram (Figure 10)

32–35

. As the excitation

photons hit the sample, the sample’s electrons are forced to a higher energy state. Then,
the electron loses energy and returns to an intermediate ground state. As the electron returns
to the ground state, it releases photons at a lower energy and longer wavelength than the
excitation light, giving the emission spectrum.

B)

A)
Energy

Alexa Fluor 488

Figure 10 (A) Jablonski Diagram (B) Alexa Fluor 488 Excitation/Emission Spectrum (A: Alexa Fluor 488 Jablonski
Diagram; B: Alexa Fluor 488 Excitation/Emission Spectrum)35,36

In our study, we used two dyes – rhodamine and Alexa 488. Rhodamine and Alexa
488 have a similarity in their structure as they both have a lot of conjugation37,38.
Conjugation refers to the double bonds that can be seen in Figures 11 and 12. These
structural properties of the molecule give rise to each dye’s unique characteristics39. This
is due to the equation for photon energy (see more in Theoretical Principles)40. Energy and
13

wavelength have an inverse relationship, and as conjugation increases, the energy barrier
decreases due to electron delocalization. Since conjugation and wavelength have a linear
relationship, as the conjugation of a structure increases, wavelength also increases. It is the
extent of conjugation that helps create these specific color properties33,39. For example,
when using rhodamine, the dye is excited with green, ~532nm, and it emits the longer
wavelength and lower energy red37. Another example is when using Alexa Fluor 488, the
dye is excited with blue, ~488nm, and it emits the lower energy of green 38,41. The benefit
of fluorescence in our study is that it allowed us to visualize individual assay components
and verify that actin-myosin bundles formed properly. As shown in a later section, by
staining the bottom layer of actin with rhodamine and the top layer with Alexa Fluor 488,
we were able to use fluorescence microscopy and the program ImageJ to verify that the
sandwiched bundles were binding together properly (see more in Methods)6,37,38,42,43.
Photobleaching, the photochemical alteration of a dye or fluorophore causing it to
lose its fluorescence, can occur with fluorescent microscopy if the sample is continuously
exposed to the excitation light. In the case of photobleaching, measures can be taken, such
as adding an oxygen scavenging unit, to preserve the life of the dyes (See Methods).

14

Figure 11 Rhodamine Phalloidin Structure37

Figure 12 Alexa Fluor 488 Phalloidin Structure38,41
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2.7

Previous Studies

To date, myosin and actin have not been studied as molecular ensembles in a
hierarchical, physiologically relevant context using optical tweezers. The only previous
work performed involves single molecule studies, which is not accurate to physiology in
vivo. However, these single molecule studies were helpful in identifying properties of
individual myosin motors and in developing a protocol for our model. An important study
was one of Ashkin’s first optical trapping papers where optical trapping of dielectric
particles by a single-beam gradient force trap was demonstrated for the first time27. These
and many other studies that have been conducted have allowed us to see the potential of
optical trapping as a tool in our study, but the most notable previous work was the threebead trapping assay of Finer et al.6,7,11,12,16,29,31,44.
The article “Single myosin molecule mechanics: piconewton forces and nanometre
steps” was an influential single molecule study to our current work. James Spudich’s group
was able to use optical trapping techniques to measure myosin mechanics at the single
molecule in the piconewton and nanometer range6,11. They used a three-bead assay in their
study that consisted of two trapped beads with actin attached to each6,27. The third bead
was stuck to the microscope slide and had myosin attached to it6. Measurements were taken
as the myosin motor contracted the actin filaments due to hydrolyzing ATP (Figure 13)6,24.
The results of this study showed that the average displacement, “step size”, of each myosin
power stroke was 11nm and the myosin produce an average force of 3-4 pN per power
stroke6,15,26. The results in this article build a strong foundation for studying myosin using
optical trapping by identifying and characterizing essential motor properties. In addition,
by having the single molecule properties of myosin moving on actin, we can use that
16

information to deduce mechanisms of how multiple myosin motors work together within
the complexes in our study6,7,27,31.

Figure 13 Three-Bead Assay (Finer et al.)6

2.8

Motivation for Current Study

HCM in patients has been studied at various levels, but the molecular basis of the
disease is still not well understood3,4. Therefore, we used a technique traditionally used for
single molecule experiments (optical trapping) to study the properties of assembled actinmyosin bundle complexes in vitro8,15. Optical trapping allows the mechanical work of
myosin molecular motors to be measured with nanometer displacements and piconewton
force resolution, while fluorescent microscopy techniques will allow for the novel bundle
assay to be visualized6,27,32,33. Previous studies show the need to make model assays that
can be engineered to study the mechanical work exerted by myosin II in a more realistic
environment6,31. Studying the mechanical properties of a more physiologically relevant
model of cardiac muscle cells will lead the scientific community to a better understanding
of the molecular basis of HCM.

17

3

Methods
3.1

Etching Coverslips

Etching microscope coverslips is an important cleaning step to make sure that there
are no contaminates remaining on the slide from the company. It also promotes a better
binding environment of the proteins onto the slide’s surface.
3.1.1 Cleaning Coverslips Protocol
1. Dissolve 100 g of KOH in 300 mL of ethanol in a beaker. Stir with a stir bar until
KOH is dissolved.
2. Put coverslips in Teflon racks.
3. Fill one beaker with 300 mL of ethanol and two more beakers with 300 mL of
reverse osmosis H2O. Degas all four beakers (KOH in ethanol, ethanol, two
beakers with water) for 5 minutes in the bath sonicator on the degas setting.
4. Submerge the rack of coverslips in the beaker with the KOH, an sonicate for 5
minutes.
5. Dip the rack of coverslips up and down in the beaker with ethanol until ethanol
runs off the coverslips smoothly (no beading).
6. Dip the rack of coverslips up and down in the beaker of water until the water runs
off the coverslips smoothly (no beading).
7. Submerge the rack of coverslips in the other beaker of water and sonicate for 5
minutes.
8. Spritz with water until the water flows off the coverslips smoothly.
9. Spritz with ethanol until the ethanol flows off the coverslips smoothly.
10. Dry the rack on the over for about 15-20 minutes.
18

3.2

Solution and Buffers

The solutions and buffers used in our study play an important role in making sure
that the integrity of the proteins is maintained. It is important to make sure that the proteins
do not denature. Solution T, TC Buffer, FC Buffer, GAB, APB, and PBS, and are all used
to keep the proteins in their optimal pH range. Without the correct pH range, the proteins
will denature and no longer function.
3.2.1 Solution T Protocol
1. In a 50 mL Falcon tube, add:
a. 3.940 g Tris-HCl
b. 0.147 g CaCl2
2. Add reverse osmosis water to 50 mL total volume and mix well. (500 mM TrisHCl and 20 mM CaCl2
3. Label Solution T and store at 4˚C.
3.2.2 TC Buffer Protocol
1. Add 40 mL of reverse osmosis water and 1.5 mL of Solution T to a 50 mL Falcon
tube. Mix well.
2. Adjust the pH to 8.0 by adding small volumes of concentrated KOH. (Usually 4-5
pellets of KOH to a 50 mL Falcon tube, fill with deionized water, and use this to
adjust pH)
3. Add water to a final volume of 50 mL and verify the pH. Adjust pH if necessary.
4. Label the tube TC and store at 4˚C.

19

3.2.3 FC Buffer Protocol
1. Mix:
a. 85 mL of reverse osmosis water
b. 10 mL of Solution T
c. 3.728 g KCl
d. 0.0406 g MgCl2
2. Adjust the pH to 7.5 by adding small volumes of concentrated KOH.
3. Add water to a final volume of 100 mL and verify the pH. Adjust pH if necessary.
4. Label the tube FC and store at 4˚C.
3.2.4 General Actin Buffer (GAB) Protocol
1. Mix:
a. 485 μL of TC buffer
b. 10 μL of 10 mM ATP
c. 5 μL of 50 mM DTT
2. Label as GAB and store at 4˚C.
3.2.5 Actin Polymerization Buffer (APB) Protocol
1. Mix:
a. 455 μL of FC buffer
b. 25 μL of 100 mM ATP
c. 20 μL of 50 mM DTT
2. Label as APB and store at 4˚C.
3.2.6 1x PBS Protocol
1. Add 24.73 g of 10x PBS powder to 250 mL buffer bottle.
20

2. Add reverse osmosis water to 250 mL total volume. Mix well.
3. Verify pH is 7.4. Adjust if necessary.
4. Need to dilute 10 times to get to 1x PBS.
5. Add 10 mL of 10x PBS and 90 mL of reverse osmosis water to a 100 mL buffer
battle. Mix well. Verify pH. Store at 4˚C

3.3

Actin Preparation

Two actin types are polymerized for each assay. We use unlabeled actin and
biotinylated actin. The biotinylated actin is important for our attachment to our streptavidin
coated beads (see more in Bundle Assembly). The biotin/streptavidin interaction is used
extensively in the optical trapping field due to it being one of the strongest noncovalent
interactions, their availability, and ease of use in trapping assays. The reconstituted actin
will be stained with rhodamine phalloidin while the reconstituted biotinylated actin will be
stained with Alexa Fluor 488 phalloidin. Phalloidin is a toxin that binds actin between
polymerized subunits and stabilizes actin filaments. By staining the polymerized actin two
different colors, we are able to verify that the bundle assay has properly formed and adhered
to the flow cell (see more in Flow Cell Assembly).
3.3.1 Polymerizing and Staining Actin Filaments Protocol
1. Reconstitute Actin by adding 100 μL of reverse osmosis water to 1 mg vial of
lyophilized actin. Mix well by pipetting up and down. Aliquot into 5 μL samples.
Store at -80˚C.
2. Thaw one vial of 10 mg/mL pure actin.
3. Prepare fresh GAB.
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4. Add 50 μL GAB and mix well by gently pipetting up and down. Place on ice for 1
hour.
5. Prepare fresh APB.
6. Polymerize actin by adding 5.5 μL of APB to the actin solution. Mix well by
pipetting up and down in a gentle fashion. Place on ice for 20 minutes.
7. Add 5 μL rhodamine phalloidin (stains and stabilizes the actin filaments). Leave on
ice in the dark for 1 hour.
8. Store in the dark at 4˚C. Stable for about 1 week.
3.3.2 Polymerizing and Staining Biotinylated Actin Filaments
Protocol
1. Reconstitute Actin by adding 100 μL of reverse osmosis water to 1 mg vial of
lyophilized actin. Mix well by pipetting up and down. Aliquot into 5 μL samples.
Store at -80˚C.
2. Reconstitute biotinylated actin by adding 20 μL of reverse osmosis water. Aliquot
5 μL samples. Store at -80˚C.
3. Thaw one vial of 10 mg/mL pure actin and 1 vial of 1 mg/mL biotinylated actin.
4. Prepare fresh GAB.
5. Add 100 μL GAB and mix well by gently pipetting gup and down. Place on ice for
1 hour.
6. Prepare fresh APB.
7. Polymerize actin by adding 11 μL of APB to the actin solution. Mix well by
pipetting up and down in a gentle fashion. Place on ice for 20 minutes.

22

8. Add 5 μL Alexa Fluor 488 phalloidin (stains and stabilizes the actin filaments).
Leave on ice in the dark for 1 hour.
9. Store in the dark at 4˚C. Stable for about 1 week.

3.4

Myosin and Bead Preparation

Myosin from Cytoskeleton, Inc. is supplied as a lyophilized powder and must be
reconstituted into the correct concentration. Beads from Spherotech need to be cleaned
once they arrive to make sure no residual contaminates are on them. The beads come
already coated in streptavidin. Streptavidin has a high binding affinity for biotin and allows
for our bead to bind to the actin biotinylated actin filaments (see more in Bundle
Assembly).
3.4.1 Reconstitute Myosin II Protocol
1. Briefly centrifuge to collect the product at the bottom of the tube.
2. Reconstitute to 10 mg/mL by the addition of 100 μL of reverse osmosis water
containing 1 mM DTT
a. 1 mM DTT in reverse osmosis water
i. 0.01542 g in 1 mL reverse osmosis water
b. Add 100 μL of 1 mM DTT to the tube
c. The protein will be in the following buffer: 25 mM PIPES, pH 7, 1.25 M
KCl, 2.5% w/v sucrose and 0.5% w/v dextran.
3. Dilute stock myosin 10x by adding 10 μL of stock myosin to 90 μL of 1 mM DTT
in reverse osmosis water.
4. Make 3 μL aliquots. Snap freeze aliquots in liquid nitrogen.
5. Store at -80˚C.
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3.4.2 Wash Streptavidin-Coated Beads Protocol
1. Dilute 20 μL 0.44 μm streptavidin-coated beads into 80 μL PBS.
2. Wash 4 times at 10,000 rpm for 6 minutes, reconstituting in 100 μL PBS.
3. Sonicate for 2 minutes at 40%.
4. Store washed beads on a rotator at 4˚C.

3.5

Flow Cell Assembly

The flow cell creates a channel that we can wash our reagents through to assemble
the bundle assay (see more in Bundle Assembly).
3.5.1 Constructing a Flow Cell Protocol
1. Combine 30 mL of ethanol with 200 μL of poly-l-lysine.
2. Soak an etched coverslip in the poly-l-lysine (promotes protein binding to the glass
coverslip) mixture for 15 minutes.
3. Take a microscope slide and apply two strips of double stick tape a few millimeters
apart.

4. Break off the excess tape.
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5. Carefully place the poly-l-lysine soaked coverslip on top perpendicular to the
microscope slide.

6. Use an epp tube to gently press against the coverslip to ensure the flow cell is
properly stuck together.

7. Flip flow cell over so that the coverslip is on the bottom. Flow cell channel should
hold 10-20 μL of liquid.
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8. Use pipets to add solutions slowly. Use Kim wipes to slowly wick the solution
through without causing the flow cell to dry out.

Figure 14 Flow Cell Assembly

3.6

Oxygen Scavenging System

The oxygen scavenging system allows for the fluorescent actin to be viewed
without photobleaching too quickly. The system extends the life of the fluorescent dyes
and allows for enough time to verify the bundle before the fluorescence gets too dim.
3.6.1 Oxygen Scavenging System Protocol
1. Glucose oxidase
a. 25 mg/mL in PBS.
b. Aliquot into 5 μL samples.
c. Store at -80˚C
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2. Beta-D-glucose
a. 500 mg/mL in PBS
b. Aliquot into 5 μL samples.
c. Store at -80˚C.
3. Catalase
a. Dilute 500 μL into 500 μL PBS.
b. Aliquot into 5 μL samples.
c. Store at -80˚C.
4. Combine 1 μL each of glucose oxidase, beta-D-glucose, and catalase when using
fluorescent dyes.

3.7

Bundle Assembly

The “bundle” is the novel model of the actin-myosin complex that we have
engineered to analyze the mechanical properties of myosin II. The bundle consists of
rhodamine stained actin bound to the coverslip with myosin II sandwiched between the
rhodamine stained actin and the Alexa Fluor 488 biotinylated actin. The Alexa Fluor 488
biotinylated actin is bound to a streptavidin coated bead (Figure 15).
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Figure 15 Desired Bundle Assay

3.7.1 Bundle Assembly Protocol
1. Dilute the Alexa Fluor 488 biotinylated actin 500x in GAB.
2. Combine 15 μL of Alexa Fluor 488 biotinylated actin, 1 μL of diluted and cleaned
streptavidin beads, 1 μL of 100 mM ATP, and the oxygen scavenging system. Put
in the rotator and let sit while the bundle is assembled.
3. Dilute the rhodamine actin 500x in GAB.
4. Add 15 μL of the 500x dilute rhodamine actin to the flow cell. Let incubate for 10
minutes in humidity chamber.
5. Wash flow cell with 10 μL of GAB. Pull through with a Kim wipe.
6. Dilute casein 10x in GAB = 1 mg/mL casein.
7. Add 10 μL of 1 mg/mL casein (blocks binding to the glass coverslip and ensures
that only rhodamine actin is bound to the glass) to the flow cell. Let incubate for 5
minutes in humidity chamber.
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8. Add 1 μL of 1 M myosin to combination in the rotator from step 2.
9. Add the combination from step 8 to the flow cell. Pull through with a Kim wipe.
10. Seal the channel of the flow cell with nail polish so it does not dry out.

3.8

Optical Trap Operation

The optical trap is a complex instrument that has specific protocols for set-up, use,
obtaining data, and analysis. The optical trap we use can be seen in Figure 16. When the
trap was delivered, one of the company’s representatives came to train all of us on the
device. The following protocol is used to load flow cells and get them into focus on the
optical trap.

Figure 16 Optical Trapping Set-Up
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3.8.1 Setting up the Optical Trap Protocol
1. Turn on the control box and the trapping laser.
2. Start the JPK optical trap computer software.
3. Turn on the laser to 50 mM, and let it stabilize for 30 minutes.
4. Remove the sample holder from the trap’s microscope stage.
5. The objectives are water immersion based. Add 30 μL of reverse osmosis water
onto the bottom objective
6. Load the flow cell coverslip down onto the stage and reinserted into the trap.
7. Raise the lower objective until the bead of water touches the coverslip.
8. Add 170 μL of reverse osmosis water to the top of the slide.
9. Lower the top objective until it breaks the surface tension of the water.
10. Begin to get the tape on the slide in focus using the bottom objective.
11. Once the tape is in focus, switch from bright field to DIC, and close the iris.
12. Bring the top objective down until you see an octagonal shape. This is to get the
objectives in Koehler illumination. Get the edges of the shape as sharp as possible.
Reopen the iris, switch back to bright field, and lock to two objectives (only lets
them move as one unit).
13. Find a bead floating in solution. Trap it by clicking the trap shutter button, which
will open the shutter to allow the trapping laser to hit the sample. Once trapped,
the bead needs to be calibrated so that voltage measurements can be correlated to
force and displacement.
14. Run the calibration routine within the software for the X, Y, and Z directions. Make
sure to “accept values” for each.

30

15. Release the bead, and find a bundle by searching for beads stuck to actin filaments.
Filaments can be visualized in DIC if they are thick enough or in fluorescence
mode.
16. Verify that a bundle is present by looking for both fluorescent actin filaments. Turn
the filter cube to 532 nm to verify the presence of the rhodamine filament in the
bundle, and then turn the filter cube to 488 nm to verify the presence of the 488
filaments.
17. Once verified, trap the bead attached to the top filament of the bundle by
unshuttering the trapping laser (click the button).
18. Click the “record data/live oscilloscope” button to record data. Choose which data
you wish to visualize (position, force, x direction, y direction), click autosave, and
click record.
19. Data will be saved as .out files. These can be exported into Excel, separated into
columns by space, and you can then analyze the recorded force and displacement
data versus time.

3.9

Analyzing Data

The data was obtained using fluorescent microscopy and optical trapping
techniques. Initial bundles were verified using Dr. Ashpole’s fluorescence microscope in
Pharmacy and subsequently viewed using ImageJ. ImageJ allowed us to verify that the two
actin filaments are truly bound. We checked these two different ways. First, we analyzed
our fluorescent images and compared the pixel to see if actin filaments were bound directly
on top of each other. Second, we combined the rhodamine and Alexa Fluor 488 channels
and saw a yellow actin filament for any bundle that was on the image. The “step size” and
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force measurements were analyzed in Excel, and the graphs were made using Igor Pro (see
more in Results).
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4

Theoretical Principles
4.1

Fluorescence Microscopy and Dyes

The basic principles behind fluorescece dye excitation and emission can be
explained by a Jablonski diagram (see Fluorescence section) and the equation for energy
of a photon9,33,40. The energy of a photon is inversely proportional to the wavelength, so as
the energy barrier decreases the wavelength must increase40. This is why we see a dye such
as rhodamine get excited with green, a shorter wavelength, and emit red, a longer, lower
energy wavelength9,37.
4.1.1 Energy of a Photon
𝐸=

ℎ𝑐
𝜆

Where E is the energy of a photon, h is Planck’s constant, c is the speed of light in a
vacuum, and λ is the wavelength of a photon40.

4.2

Optical Trapping

The force acting on a bead in an optical trap acts similarly to a spring, so we can
use Hooke’s Law to find the force exerted by myosin II6,27,45. Trap calibration plays an
integral role in taking accurate data29,31,34. Once the trap is calibrated, the force can be
calculated using Hooke’s Law45. The calibration step uses the known energy of the laser to
find the trap stiffness (ktrap; how tightly the bead is held in the center of the trap)29. Once
the trap stiffness is known, the optical trap will record the displacement of the bead from
the center of the laser. Knowing the trap stiffness and the displacement of the bead allows
for the calculation of the force that was exerted by the molecular motor6,11,45.
There are three main calibration methods, and the optical trap we use is calibrated
using the power spectrum method. The power spectrum method is a calibration method
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that utilized the natural fluctuation in Brownian motion of the bead trapped in fluid to find
the stiffness of the trap29,46. The calibration method assumes that the system is linear and
in a harmonic potential. A harmonic oscillatory system is one that experiences a restoring
force proportional to the displacement when displaced from its equilibrium position47. For
the power spectrum method in an ideal system, we know the temperature of the fluid on
the slide and the Boltzmann constant, so we can calculate the stiffness of the trap by
watching the displacement of the bead due to Brownian motion. However, the calculation
is not that simple because the bead will fluctuate differently based on the different
frequencies that interact with the bead. Since the bead will have a spectrum of fluctuation,
the power spectrum corrects for this. The spectral density, or bead displacement within the
laser trap, will be plotted, and the trap stiffness can be determined from the corner
frequency, which is a boundary in a system’s frequency response at which energy flowing
through the system begins to be reduced rather than passing through (Figure 17)46,48. By
measuring the power spectrum, we are able to calculate the corner frequency allowing us
to find the trap stiffness since we know the drag force for the bead46.

Figure 17 Power Spectrum Method (Example of a corner frequency)29
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4.2.1 Hooke’s Law Derivation
Definition of the potential energy stored in a spring:
1

𝑈 = 2 𝑘(𝑥 − 𝑥0 )2

(1)

Where U is the potential energy stored in a spring, K is the spring constant, x is the change
in length, and x0 is the equilibrium length. Assuming:
𝑥0 = 0; 𝑥𝑖 = 𝑥; 𝑥𝑓 = 𝑥 + 𝑑𝑥

(2)

Where dr is a very small change in length. Now looking at the change in potential energy:
𝑑𝑈 = 𝑈𝑓 − 𝑈𝑖

(3)

Plugging in (2) to (3), we get:
1

1

𝑑𝑈 = 2 𝑘(𝑥 − 𝑥0 )2 − 2 𝑘𝑥 2

(4)

Expanding (4), we get:
1

1

𝑑𝑈 = 2 𝑘(𝑥 2 + 2𝑥𝑑𝑥 + 𝑑𝑥 2 ) − 2 𝑘𝑥 2

(5)

Simplifying (5), we get:
1

𝑑𝑈 = 𝑘𝑥𝑑𝑥 + 2 𝑘𝑑𝑥 2

(6)

If dx << 1, dx2 → 0 and we get:
𝑑𝑈 = 𝑘𝑥𝑑𝑥

(7)

Now looking at the conservation of energy equation:
𝑑𝐸 = 𝑑𝐾 + 𝑑𝑈 = 0

(8)
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Where K is the kinetic energy and E is the mechanical energy. Setting (8) equal to zero,
we get:
𝑑𝐾 + 𝑘𝑥𝑑𝑥 = 0

(9)

Rearranging (9), we get:
𝑑𝐾 = −𝑘𝑥𝑑𝑥

(10)

Now looking at the work-energy theorem:
𝑑𝐾 = 𝐹⃑ ∙ 𝑑𝑥⃑

(11)

Where 𝐹⃑ is the force vector and 𝑑𝑥⃑ is the displacement vector. Assuming the force vector
and displacement vector are going in the same direction, we see:
𝐹⃑ ∙ 𝑑𝑥⃑ = 𝐹𝑑𝑥𝑐𝑜𝑠𝜃; 𝑐𝑜𝑠𝜃 → 1

(12)

Simplifying (12), we get:
𝐹⃑ ∙ 𝑑𝑥⃑ = 𝐹𝑑𝑥

(13)

Combining (10), (11), and (13), we get Hooke’s Law:
(14)49

𝐹𝑡𝑟𝑎𝑝 = −𝑘𝑡𝑟𝑎𝑝 𝑥

4.2.2 Equipartition and Power Spectrum Method Derivation
1

Brownian motion of the trapped bead is equal to 2 𝑘𝐵 𝑇, whereas the potential energy of a
spring is equal to

1
2

∝ 𝑥 2 . The equipartition method of calibration is accomplished by

setting these two energies equal and solving for the stiffness:
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∝=

(𝑥 2)

(1)

𝑘𝐵 𝑇

Where ∝ is the spring stiffness, x is the displacement of the bead, kB is the Boltzmann
constant, and T is the temperature of the liquid medium. Now, measuring the frequency
spectrum of the Brownian noise exhibited by the bead, the mass of the bead is typically so
small that the Reynolds number is very low and inertial forces are much weaker than those
of hydrodynamic drag. This leads to the equation of motion for the bead being that of a
massless, damped oscillator driven by Brownian motion:
𝛽𝑥̇ (𝑡) + 𝛼𝑥(𝑡) = 𝐹(𝑡)
Where x is the position of the bead, β=6

(2)

r is the drag coefficient of the bead,

is the

viscosity of the surrounding fluid, and r is the bead radius. The Brownian noise source, F(t)
has zero mean, and essentially white with amplitude:
2
|𝐹̃ (𝑓)| = 4𝛽𝑘𝐵 𝑇

(3)

Where β is the drag coefficient of the bead, kB is the Boltzmann constant, and T is the
temperature. Taking the Fourier transform, 𝐹̃ (𝑓); 𝑥̃(𝑓), of (3) gives:
𝛼
2𝜋𝛽 (2𝜋𝛽 − 𝑖𝑓) 𝑥̃ (𝑓) = 𝐹̃ (𝑓)

(4)

Where 𝑖 is the imaginary unit. Therefore, the power spectrum is then given by:
|𝑥̃(𝑓)|2 =

𝑘𝐵 𝑇
𝛼 2
2
𝜋 𝛽[(
) +𝑓 2 ]
2𝜋𝛽
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(5)

𝛼

Equation (5) is that of a Lorentzian with corner frequency 𝑓𝑐 = 2𝜋𝛽 , so the stiffness of the
trap is then given by 𝛼 = 2𝜋𝛽𝑓𝑐 . This method must be repeated for the x, y, and z
direction29,46.
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5

Results and Discussion
5.1

Developing a Protocol

Since we had to develop this new and novel cytoskeletal model, an important part
of our study was to verify and build a protocol to assemble the actin-myosin bundle assay.
We hypothesized that if we promoted binding by soaking the coverslip in poly-l-lysine to
promote binding, we could then push actin through the flow cell and it will bind to the
surface of the coverslip. Poly-l-lysine is able promote binding because it is positively
charged while actin has many negative charges on its surface. Then, excess actin will be
flushed out by washing the flow cell with GAB. We do not want our subsequent proteins
and actin filaments to bind to the positively charged surface; we want everything else to
bind to the prebound actin filaments. Therefore, we block the binding to the surface by
pushing casein, a common blocking protein, through the flow cell. Now that surface
binding is blocked, we can push biotinylated actin, myosin, and ADP (putting myosin in
its strongest binding conformation; ATP would be subsequently added in to the actual assay
to facilitate force generation) into the flow cell causing myosin to bind and sandwich
between the two actin filaments. Before we begin assembling the bundle, we had to make
sure that the actin concentration allowed the visualization of single actin filaments. We
started by polymerizing and staining actin filament to make sure that we were able to
visualize the actin filaments. Once the actin filaments were polymerized and stained, we
viewed them under the fluorescent microscope. Our initial protocol was successful but too
concentrated to effectively build bundles; so, we tried dilutions until we found that the
500x dilute actin gave us enough space between actin filaments to allow for the
measurement of a single bundle assay (Figure 18). Now that we are able to get the actin
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filaments into a working concentration, we can begin assembling the bundle assay and
tweak the concentrations of the bundle protocol.

Figure 18 Fluorescent Actin Filaments (Top left: 500x dilute rhodamine actin; Top right: concentrated rhodamine
actin; Bottom left: concentrated Alexa Fluor 488 actin; Bottom right: 500x dilute Alexa Fluor 488 actin)

5.2

Verifying the Bundle Assay

To verify the bundle assay was created, we continued to use fluorescent microscopy
techniques. Since we stained our actin with two different dyes, we were able to put the flow
cell with the bundles into a fluorescent microscope and take pictures of the same frame in
both the rhodamine and Alexa Fluor 488 channels. Once the images were taken, we were
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able to analyze them using ImageJ and compare each pixel on the side by side frames to
see if any bundles were formed and perfectly lined up with one another, which would verify
that binding had occurred (Figure 19). Although we verified that the bundle assays were
forming correctly, we saw that the actin filaments were breaking apart while we were
viewing them on the microscope. This led us to believe that the concentration of myosin II
was too high compared to the concentration of actin used, and the force and conformations
of the myosin were causing the actin filaments to break. After adjusting the myosin
concentration, we saw stable bundle assays that were spaced far enough apart from each
other that they could be analyzed; so, we moved into the next phase of our study and began
taking preliminary force data of the bundle assay.

Figure 19 Bundle Assay Formation Verification

5.3

Preliminary Measurements

Now that bundle assay formation is verified, we began taking force generation data
of the actin-myosin complex with optical tweezers. First, we trapped an unbound bead in
solution and used this bead to calibrate the optical tweezers. We then analyzed the results
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of the unbound bead as a control (Figure 20). The unbound bead should produce no data
other than Brownian motion – the natural random movement of a particle in solution due
to molecules colliding. As seen in Figure 20, the unbound bead showed almost no change
in displacement or force and oscillated at baseline. The control measurement verified that
the trap was calibrated, and we could begin analyzing the bundle assays. We identified a
bundle assay with a streptavidin bead attached to the Alexa Fluor 488 biotinylated actin
and trapped the streptavidin bead using the optical tweezers. We were able to obtain
multiple traces from multiple bundles on each flow cell that we made. After analyzing the
data, we observed that myosin II at the concentration used produced a logarithmic growth
pattern (Figure 21-22). In Figure 21 and 22, we can see that the position/force vs. time
graph staircases up to a maximum output. The preliminary results of this study showed that
in our novel model of the actin-myosin complex, myosin II was able to produce a force
between 0.5-3 pN and an average force of 1.3 pN. The myosin II “step size” had more
variability but ranged between 5-8 nm on average.

Figure 20 Control Trap Measurement (Bead trapped in solution)
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Figure 21 Representative Bundle Trap Measurement 1 (Left: bead trapped and attached to a bundle assay; Right:
image of the bead and the highlighted bundle it is attached to)

Figure 22 Representative Bundle Trap Measurement 2 (Left: bead trapped and attached to a bundle assay; Right:
image of the bead and the highlighted bundle it is attached to)
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6

Conclusions and Future Work
The work conducted thus far validates the hypothesis that a new and novel model

of the actin-myosin complex could be engineered, and fluorescent microscopy and optical
trapping techniques could be used to analyze myosin II’s biophysical properties. Our
results showed that the “step size” varied and had an average range of 5-8 nm, which was
conclusive with myosin studies6,12. The interesting difference seen was in the force output
of the myosin. Our results showed an average for of 1.3 pN, which was less than the 3-4
pN force outputs seen in previous single myosin molecule studies6,12. We hypothesize that
the average force in the multiple myosin and actin system is due to competing forces acting
in opposite directions causing an antagonizing motion and net force generation that is less.
These preliminary studies were the first experiments performed in the Reinemann lab, so
there are not any hard conclusions yet from this study. However, it helped confirmed our
lab’s hypothesis, developed and optimized the protocols for this study, and built a
foundation on which we can continue to study this project. Looking forward, the
Reinemann Lab Group will continue analyzing healthy myosin models and begin to
analyze models with diseased myosin to see if the diseased myosin model’s biophysical
properties differ from the normal (control) myosin model. Continuing to study the
mechanical properties of this more physiologically relevant model of cardiac muscle cells
will lead the scientific community to a better understanding of the molecular basis of
hypertrophic cardiomyopathy.
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